ABSTRACT
D
evelopmental venous anomalies are considered developmental variations in the venous drainage pathway for a portion of the brain parenchyma. [1] [2] [3] [4] DVAs are generally discovered incidentally and are considered benign. While there have been some reports of DVAs presenting with hemorrhage or neurologic symptoms, [4] [5] [6] [7] it is unclear and controversial whether this association reflects a causal relationship. There is a clear association between DVAs and cavernous malformations, and perhaps hemorrhage, with cavernous malformations found in up to 33%-48% of DVAs in some series. 3, 8 The reasons behind the tendency of some DVAs to be associated with symptoms or to develop CMs are not fully understood. Various mechanisms have been proposed for clinical manifestations of DVAs, including mechanical compression of the adjacent brain parenchyma, diminished venous outflow across the brain parenchyma drained by the DVA, increased flow related to arterialization of the DVA, stenosis of the draining vein, or the tortuosity of the venous tributaries. 2, 9 While Ն1 of these factors may be at play in affecting risk of hemorrhage or CM formation in a given DVA, all these factors are likely to affect the hemodynamics of the blood flow in the brain parenchyma that the DVA is draining. In small case series of 3-4 cases, previous authors have shown that such altered hemodynamics may be manifest in the perfusion maps generated from the PWI. 10, 11 A more in-depth study into such perfusion abnormalities may help to better characterize focal hemodynamic alterations in the brain tissue drained by the DVAs and their potential association with hemorrhage/CM formation. Our purpose was to study the perfusion alteration in the brain parenchyma drained by DVAs by using PWI and to investigate differences in the perfusion parameters around DVAs with and without CMs.
MATERIALS AND METHODS
This prospective study was approved by our institutional review board and conducted in compliance with the Health Insurance Portability and Accountability Act. All patients signed written consent documents to participate.
Patient Selection
The inclusion criteria were the presence of a brain DVA (with or without a CM) diagnosed on prior MR imaging, in the absence of other structural abnormalities of the brain. Potential candidates for the study were identified at our vascular-neurosurgery clinic and by searching the radiology report data base of our institution by using the terms "developmental venous anomaly," "DVA," "venous anomaly," and "venous angioma." The exclusion criteria were the following: 1) inability to clearly delineate the intraparenchymal course of the venous tributaries of the DVA; 2) midline location of the DVA that precluded a comparison with the contralateral normal brain tissue; 3) claustrophobia, contrast reaction, estimated glomerular filtration rate of Ͻ60 mL/min, or any other contraindication to contrast-enhanced MR imaging; and 4) age younger than 18 years.
All qualifying patients were contacted via telephone and invited to participate in the study. A patient who agreed to participate underwent contrast-enhanced MR imaging that included PWI. We were able to identify 66 eligible patients. Of these, 24 (11 men and 13 women) opted to participate and underwent MR imaging between July 2009 and May 2011. The patients ranged from 21 to 75 years of age. At the end of the study, we had 15 DVAs without and 10 with CMs. Eighty-eight percent of DVAs (22/25) were supratentorial, most involving the frontal lobe (6/25, 24%). For DVAs without CMs, the presenting symptoms included headaches in 7 DVAs, and seizures in 1. Seven DVAs without CMs were discovered incidentally. For DVAs with CM, 4 were incidentally discovered, while the presenting symptoms included headaches in 4, seizures in 1, and slurred speech in 1. With the exception of 1 DVA with a CM in a patient who presented with slurred speech related to acute hemorrhage, it was unclear whether any of the symptoms were directly related to DVAs.
Image Acquisition and Postprocessing
MR imaging was performed on a 1.5T scanner (Avanto; Siemens, Erlangen, Germany). The scan included axial T1WI, axial FLAIR imaging, axial SWI, PWI, and postcontrast axial and coronal T1WI. In addition, MR venograms were obtained by using a time-of-flight technique. PWI was performed by using a dynamic susceptibility-weighted imaging technique with intravenous injection of 0.1 mmol/kg of gadoversetamide (OptiMARK; TycoHealthcare/Mallinckrodt, St. Louis, Missouri) at a rate of 4 mL/s.
The perfusion data were postprocessed on a postprocessing workstation (Leonardo; Siemens) by one of the authors (A.S. with Ͼ10 years of experience in neuroradiology) to generate standard perfusion maps for relative CBV, relative CBF, and relative MTT. The right middle cerebral artery branches within the Sylvian fissure ipsilateral to the DVA were selected to define the arterial input function.
Calculation of Relative Perfusion Values for Brain Parenchyma around the DVAs
For each perfusion map, we selected 3 ROIs in the brain tissue around the DVA tributaries, using the conventional imaging sequences to exclude the venous tributaries or the CM (Fig 1) . Each region of interest provided a numeric value (along with an SD, which was not used for analysis) representing the perfusion of the brain in that region (Fig 1C) . A corresponding value was calculated by using an identically sized region of interest in a mirror image location in the contralateral brain (Fig 1D) . The ratio of these 2 values provided a measure of brain perfusion around a DVA for the given region of interest, relative to the contralateral brain with normal venous drainage. The arithmetic mean of the ratios for the 3 ROIs was used to calculate rCBV, rCBF, and rMTT representing the relative perfusion of brain around the DVA.
Calculation of Relative Perfusion Values for Brain Parenchyma with Normal Venous Drainage
To assure validity of our methods, we also calculated control perfusion values for the brain with normal venous drainage (ipsilateral to the DVA), relative to the contralateral side ( Fig 1D) . For these, 1-cm 2 ROIs were drawn on the perfusion maps in the white matter of the frontal lobe, parietal lobe, occipital lobe, and cerebellar hemisphere, unless one of these regions could not be included due to the presence of a large DVA. The arithmetic mean of ratios thus generated was considered to represent control values of relative perfusion for brain parenchyma with normal venous drainage, designated as cCBV, cCBF, and cMTT.
Statistical Analysis
Perfusion parameters around DVAs (rCBV, rCBF, and rMTT) were compared with corresponding control values (cCBV, cCBF, and cMTT, respectively). In addition, rCBV, rCBF, and rMTT for DVAs without CMs were compared with the corresponding values for DVAs with CMs. Normal curves were fitted to data distributions, and the normality of the distributions was tested with the Shapiro-Wilk W-test. Ninety-five percent confidence intervals (95% CIs) were calculated for normally distributed data, and medians and ranges were calculated for non-normally distributed data. Equality of variances was tested with the O'Brien, BrownForsythe, Levene, and Bartlett tests. Differences between independent group means for normally distributed data with equal variances were tested with the Student t test. For non-normally distributed data with equal variances, the nonparametric Wilcoxon rank sum test was used. For data with normal distributions but nonequal variances, the t test (assuming unequal variances) was used. For comparisons of paired group means, if the differences were normally distributed, the paired t test was used; if the differences were non-normally distributed, the Wilcoxon rank sum was used. For categoric data comparisons, the exact P value for the Fisher exact test was calculated through data permutation. ␣ was set at .05, and 2-tailed tests were used. Statistical analyses were performed with JMP Statistical Software, Release 9.0.0 (SAS Institute, Cary, North Carolina) and StatXact-9 statistical software for exact nonparametric inference (Cytel, Cambridge, Massachusetts).
RESULTS

Perfusion Parameters
For the perfusion parameters studied, Ta 
Comparison of DVAs with and without CMs
For the perfusion parameters in DVAs with and without CMs, Fig 2 contains plots of the values for perfusion parameters and The location of DVAs did not differ significantly between the CM and non-CM groups (Fisher exact test, P ϭ .46).
DISCUSSION
In view of the presence of some degree of altered perfusion around all the DVAs studied, our results indicate that the presence of a DVA is likely to be inherently associated with altered hemodynamics in the involved brain parenchyma. While supporting previous findings, 10, 11 our results indicate that PWI is able to detect such perfusion alterations around most DVAs, not just anecdotal cases. The pattern of perfusion abnormalities in our study was also similar to that seen previously, 10,11 with higher relative CBV as well as MTT in the brain around the DVAs. A variable change in relative CBF (Fig 3) is also in accordance with that in previous studies. [10] [11] [12] The pathogenesis of DVAs is not fully understood. Some investigators consider them to result from in utero thromboses of the developing venous system. 2, 3, 13, 14 The dilated medullary veins converging onto a prominent collector channel in effect serve as a replacement of the normal venous system that would have otherwise existed in this part of the brain. 2 Consistent elevation of rMTT and rCBV seen in our study supports this model of DVA pathogenesis of a venous outflow, inherently less robust than normal venous drainage. Similar prolongation of MTT on PWI has been seen in the setting of other conditions affecting venous outflow, such as dural venous thrombosis or patients with SturgeWeber syndrome. [15] [16] [17] This increase in the MTT for DVAs, however, appears to be due to alterations in the CBV and CBF that follow a pattern distinct from that seen in other restrictive venous pathologies. As per the central volume theorem, MTT is simply a ratio of CBV and CBF. 18 Prolongation of MTT in the presence of venous outflow restriction is usually the result of venous engorgement-induced increase in CBV, along with outflow restrictioninduced reduction in CBF, as has been shown in diseases such as Sturge-Weber syndrome. 16, 17 In contrast, in most of the DVAs studied by us and in previous reports, the increase in rMTT was seen in the setting of increased rCBV and a less pronounced increase in the rCBF. While the increased rCBV is easy to explain, elevation of rCBF around many DVAs is more difficult to explain solely on the basis of alterations in the venous development. Modest reactive vasodilation in arterioles has been demonstrated in response to venous dilation in animal studies. 19 However, it is unlikely that such a reactive change is able to more than overcome the restrictive effects of the outflow restriction in the presence of venous outflow obstruction. The exact explanation for increased rCBF around DVAs remains unclear. However, it is possible that the developmental nature of the venous anomalies (as opposed to the acquired nature of venous obstruction in experimental models/pathologic venous obstruction) is somehow unique in that the etiologic factors responsible for formation of DVAs are also able to induce developmental changes in the arterial inflow that try to minimize stasis of blood in the affected brain by increasing the CBF in the face of increased CBV. A control cerebral blood flow indicator of close to 1 in brain parenchyma with normal venous drainage would argue against the possibility that these elevated relative CBF values are somehow representing artifacts. Pathophysiologic implications of these results are also highlighted by the observed differences in the perfusion parameters of DVAs with and without CMs. A greater prolongation of MTT and a trend toward a lesser increase (or even decrease in individual cases) of rCBF in the CM group may be related to greater restrictive effects of DVAs in this group. Significant quantifiable differences in the perfusion parameters around developmental venous anomalies with and without associated cavernous malformations may reflect the role of hemodynamic factors in the development of these malformations. We hypothesize that in a large number of DVAs, the diminished venous capacity still has enough reserves to accommodate the physiologic needs, and such DVAs may remain completely asymptomatic. In other DVAs however, the restrictive effects on the venous drainage may be enough to cause local venous hypertension and thereby the propensity of these vessels to bleed and result in localized hemorrhage and subsequent CM formation. Given that the medullary veins composing the tributaries of the DVA are also known to have thinner walls, such veins may be more prone to bleed with this local venous hypertension. 20 DVAs generally fill later in the venous phase on catheter angiography. Our find- 
